Latest News

Call-to-Action: Senate Health Care Bill Released and Vote Expected Next Week

June 23, 2017
Posted in ,

Yesterday, members of the Senate released draft text of their much awaited legislation called the Better Care Reconciliation Act (“Better Care Act”) of 2017. As you’ll recall from previous updates […]

Read More ›

Cure SMA Update – Senate Healthcare Bill

June 21, 2017
Posted in ,

The US Senate is currently working on legislation to modify the Affordable Care Act. Though details of the Senate’s plan are not yet available, legislation could be released as early […]

Read More ›

Launch of Phase 2 SMA Industry Collaboration Announced

June 20, 2017
Posted in

Cure SMA is pleased to announce the launch of Phase 2 of our SMA Industry Collaboration. The SMA Industry Collaboration is a multi-faceted partnership that brings together pharmaceutical companies, Cure […]

Read More ›

2017 Annual SMA Conference Booklet Now Posted

June 16, 2017
Posted in ,

The 2017 Annual SMA Conference Booklet is now posted. The booklet includes: A complete schedule with information about the special events we’ve got planned including: the Family Friendly Research Poster […]

Read More ›

SMA Newborn Screening Moves Forward in Missouri and Florida

June 15, 2017
Posted in , ,

The spinal muscular atrophy community is celebrating significant progress toward adding SMA to newborn screening panels in two states. Missouri to Become the First State to Screen for SMA In […]

Read More ›

AveXis Announces Alignment with the FDA on Company’s GMP Commercial Manufacturing Process for AVXS-101

June 14, 2017
Posted in ,

AveXis today announced alignment with the U.S. Food and Drug Administration (FDA) on the company’s Good Manufacturing Practice (GMP) commercial manufacturing process for AVXS-101 following the receipt of minutes from […]

Read More ›
Scroll to Top